Wikidata

(Q53399392)

English

Efficacy of ICS 205-930, a novel 5-hydroxytryptamine3 (5-HT3) receptor antagonist, in the prevention of migraine attacks. A complex answer to a simple question. ICS 205-930 Migraine Study Group.

scientific article published in June 1991

In more languages

Statements

title
Efficacy of ICS 205-930, a novel 5-hydroxytryptamine3 (5-HT3) receptor antagonist, in the prevention of migraine attacks. A complex answer to a simple question. ICS 205-930 Migraine Study Group. (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
1876437
retrieved
13 May 2018
reference URL
http://europepmc.org/abstract/MED/1876437

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q53399392&oldid=1077787691"